Navigation Links
ProMetic announces scale-up of prion removal resin in plasma product for biopharmaceutical use
Date:1/23/2008

n, particularly if different genetic subgroups are found but with longer incubation periods".

About ProMetic Life Sciences Inc.

ProMetic Life Sciences Inc. ("ProMetic") (http://www.prometic.com) is a biopharmaceutical company specialized in the research, development, manufacture and marketing of a variety of commercial applications derived from its proprietary Mimetic Ligand(TM) technology. This technology is used in large-scale purification of biologics and the elimination of pathogens. ProMetic is also active in therapeutic drug development with the mission to bring to market effective, innovative, lower cost, less toxic products for the treatment of hematology and cancer. Its drug discovery platform is focused on replacing complex, expensive proteins with synthetic "drug-like" protein mimetics. Headquartered in Montreal (Canada), ProMetic has R&D facilities in the U.K., the U.S. and Canada, manufacturing facilities in the U.K. and business development activities in the US, Europe, Asia and in the Middle-East.

About ProMetic BioSciences Ltd

Using its unique and proprietary Mimetic Ligand(TM) technology, ProMetic BioSciences Ltd ("PBL") specializes in the development and manufacture of robust affinity separation materials which provide very high levels of purification. This is achieved by use of small chemical affinity ligands designed to bind a target biomolecule specifically and reversibly. In view of their use for the production of therapeutics, ProMetic's affinity products are manufactured to strict quality standards at PBL's GMP-compliant manufacturing facility on the Isle of Man, which completed a (pnds stlg)1.5 million expansion in 2005. PBL also operates an R&D laboratory located on the Cambridge Science Park, UK.

About Pathogen Removal and Diagnostic Technologies Inc.

Pathogen Removal and Diagnostic Technologies Inc. ("PRDT") is a joint venture established in Apri
'/>"/>

SOURCE PROMETIC LIFE SCIENCES INC.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. ProMetic and MacoPharma announce successful completion of P-Capt(R) prion reduction filter clinical studies
2. Vapotherm(R) Announces Validation of U.S. Patent
3. Synosia Announces Encouraging Results of Proof-of-Concept Clinical Trial for Epilepsy Drug rufinamide as a Treatment for Mood Disorders
4. Abbott Announces Approval of First Fully Automated Blood Screening Test for HTLV-I/HTLV-II
5. Elekta Announces First Two Clinical Sites Using VMAT Cancer Treatment Capability
6. Amarin Provides Business Update and Announces Implementation of Reverse Stock Split
7. Alfacell Announces ONCONASE(R) Purchase and Supply Agreement with Scientific Protein Laboratories
8. Peptimmune Announces First Close of Series D Private Financing
9. Schering-Plough Announces Sugammadex New Drug Application Filed in Japan
10. Gen-Probe Announces Webcast of Fourth Quarter and Full Year 2007 Earnings Conference Call
11. Vasogen Announces 2007 Year-End Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...wire/ -- The world,s first concept demonstration ...rough alternative to replace a petrochemically pro...ubber with renewable biomass, made their debut in ...n display at a lounge in the common departure area...t December 21, while the other tire will make appe...
(Date:12/2/2009).... 2 TechConnect World, an event br...ent and product integration in cleantech, nanotech...adline for technology abstracts and business prese...World, in association with the Nano Science and Te...y and Sustainable Industries Organization (CTSI), ...
(Date:12/2/2009)...wire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: ...maceutical company focused on endocrine therapy an... Drug Administration (FDA) has granted Fast Track ...ibitor compound, perifosine (KRX-0401), for the tr...eryx Biopharmaceuticals, Inc. ("Keryx") ( KERX), i...
(Date:12/1/2009)...1 PDL BioPharma, Inc. (P...nce for the fourth quarter ended December 31, 2009...9 million for the fourth quarter of 2008. Included...wo installment payments of $12.5 million from Alex... was a one-time $1.8 million payment from Genentec...
Breaking Biology Technology:The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 2The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 3Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 3AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 2PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 3
...n, Wis. Third Wave Technologies Inc. , a Madison ...stic reagents for DNA and RNA analysis application... , ,Napier,s background in general management and ...ve, according to president and CEO Kevin T. Conroy...omen,s markets in the promotion of products at Pr...
...ille, Wis. - Fighting cancer and disposing of exc...first glance. However, a small company in Janesvil...omises to tackle both problems simultaneously. , ,... developer of radiopharmaceuticals, will develop a...ssing small amounts of unused nuclear fuel left ov...
...kee, Wis. - Lifeblood Medical, Inc., a Freehol....25 million in a Series B financing involving 21 p...financing, coordinated through Frederick & Co ., ...feblood Medical to proceed with plans to hire key ... approval for its LIFOR organ preservation solutio...
Other Biology Technology:Napier joins board of Third Wave Technologies 2NorthStar finds cancer-fighting use for nuclear fuel 2Wisconsin investors the lifeblood of New Jersey biotech 2
(Date:12/4/2009)...skovar, a Texas AgriLife Research plant physiologi...nter in Uvalde, has been investigating ways to hel...n from the greenhouse to the field. , "This rese...ibly even the further profitability of some vegeta... plants that will establish well," Leskovar said. ...
(Date:12/4/2009)...lable in German . , A new study of the Max Pl... understand the positive effect of dietary restric...ferent organisms (fruit flies and mice) have shown... with a potential negative side effect of diminish...ess frequently with a reduced litter size on a low...
(Date:12/3/2009)...n new information and adapt to changes in our dail...ies, appears to lie in the minute junctions where ...by NYU Langone Medicine Center researchers. The st...Nature . , The scientists, led by Wen-Biao Gan,...cience at NYU School of Medicine, discovered that ...
Breaking Biology News(10 mins):Texas AgriLife researchers helping 2Texas AgriLife researchers helping 3Texas AgriLife researchers helping 4How nutrition affects healthy aging 2Lifelong memories linked to stable nerve connections 2NIDDK announces availability of more current kidney disease data 58802 1NIDDK announces availability of more current kidney disease data 58802 2The real world of a forensic scientist 10247 1The real world of a forensic scientist 10247 2Uncertainty Surrounds Testing for Alzheimers 58797 1Uncertainty Surrounds Testing for Alzheimers 58797 2Uncertainty Surrounds Testing for Alzheimers 58797 3
...onian forest at twice the rate previously estimate...ogging to those of clear-cutting. The research app...ce , published by AAAS, the nonprofit science soci...uring deforestation across large areas have only b... where all the trees are removed to clear space fo...
...or people with compromised immune systems may be f...ers, who demonstrated their approach could protect...e same population of immune cells that HIV destroy...ldren,s Hospital of Pittsburgh researchers, workin...rsity of Pittsburgh and Louisiana State University...
...ems for understanding fungal diseases, two groups ...insight into how carbon dioxide (CO2) governs the ... survive in different environments and invade the ...CO2 sensing and metabolism utilize evolutionarily ... reproduction of pathogenic microbes. , The two s...
Other Biology News:Logging doubles threat to the Amazon, rivaling clear-cutting, study suggests 2New vaccine platform may fight infections with causes from influenza to bioterrorism 2New vaccine platform may fight infections with causes from influenza to bioterrorism 3CO2 sensing proves critical for fungal pathogens to adapt to life in air and human hosts 2CO2 sensing proves critical for fungal pathogens to adapt to life in air and human hosts 3
...ed Console Orbital Shakers combine high durability...equalled programming power. The patented triple-c...tion, allowing the unit to run with heavy out-of-b...educes contamination. The heavy stainless steel i...
Immulon 1 B 1x12 Strip from Thermo Scientific
Horizontal Plus 0.9 (230V / 50Hz) from Thermo Scientific
RapidStak from Thermo Scientific
Biology Products: